Friday, May 24, 2024
102 F
Peshawar

Where Information Sparks Brilliance

HomeHealthLilly trades at a premium to Ozempic maker Novo as obesity drugs...

Lilly trades at a premium to Ozempic maker Novo as obesity drugs boom. Here’s why, analyst says




Source link

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

 

Recent Comments